跳至主要内容
临床试验/NL-OMON50917
NL-OMON50917招募中不适用

DIAGNOSTIC ARTHROSCOPY VERSUS ARTHROCENTESIS AS INITIAL TREATMENT FOR ARTHRALGIA OF THE TEMPOROMANDIBULAR JOINT A mono-center single-blind randomized controlled trial - DIAMOND trial

niversitair Medisch Centrum Groningen0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients aged 18 years or older.
  • - Arthralgia of the Temporomandibular joint (TMJ), proven with a diagnostic
  • intra-articular injection with Ultracain DS Forte.
  • - TMJ pain still present after two weeks of NSAIDs
  • - Symptoms presenting unilaterally or bilaterally with at least one TMJ with a
  • Visual Analog Scale-score < 30 mm during movement or function, after
  • anesthetizing the contralateral joint.

排除标准

  • - Systemic rheumatic disease
  • - Bony ankylosis of the Temporomandibular Joint (TMJ)
  • - Congenital or acquired dentofacial deformity
  • - History of jaw trauma that resulted in jaw or joint pain, bony changes or
  • mandibular growth restriction
  • - Prior arthrocentesis, (diagnostic) arthroscopy or open-TMJ surgery
  • - Psychiatric disorder (as diagnosed by a physician)
  • - Unwillingness to receive one of the study treatments
  • - Pregnancy at time of treatment
  • - Concurrent use of steroids, muscle relaxants or anti-inflammatory drugs other
  • than the previously prescribed NSAIDs
  • - Incompetence to speak the Dutch or English language
  • - Coagulation disorders, diabetes mellitus type I or II, kidney failure, heart
  • failure, cardiac ischemia, hypertension and history of HIV.

研究者

相似试验